Swiss National Bank Sells 98,300 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Swiss National Bank decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 4.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,072,900 shares of the pharmacy operator's stock after selling 98,300 shares during the period. Swiss National Bank owned about 0.24% of Walgreens Boots Alliance worth $19,340,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Riverview Trust Co lifted its holdings in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC lifted its holdings in Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after purchasing an additional 3,208 shares during the last quarter. Institutional investors own 58.59% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Royal Bank of Canada lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Finally, Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of "Hold" and an average target price of $10.59.

Remove Ads

Walgreens Boots Alliance Price Performance

Shares of WBA traded down $0.02 during midday trading on Friday, hitting $11.10. The company's stock had a trading volume of 37,249,707 shares, compared to its average volume of 20,761,826. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05. The company's fifty day simple moving average is $10.96 and its two-hundred day simple moving average is $9.82. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.59 billion, a price-to-earnings ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.